Cyclohexane

Cyclohexane

SCHEMBL2585876

C1CCCCC1.CCC(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.83
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
TDP1 Q9NUW8 4/20 0.47
ALDH1A1 P00352 3/20 0.47
AKR1B1 P15121 1/20 0.40
LDHA P00338 1/20 0.40
SRR Q9GZT4 1/20 0.40
LMNA P02545 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
SUCNR1 Q9BXA5 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
CYP2C19 P33261 1/20 0.39
PPARG P37231 6/20 0.38
PPARD Q03181 6/20 0.38
PPARA Q07869 6/20 0.38
HDAC11 Q96DB2 5/20 0.38
TSHR P16473 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL27344153 1.00
Propionic Acid SCHEMBL28008056 1.00
Propionic Acid SCHEMBL29094849 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclopentane SCHEMBL97373 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL5062880 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclooctane SCHEMBL27748002 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL4093030 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclopentane SCHEMBL28987168 1.00 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL29144978 0.96 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL11710549 0.96 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025233177-A1 LONG-DURATION FORMULATION GLYCOSCIENCE, S.L. (ES) 2025-11-13 WO claimed
EP-4646930-A1 LONG-DURATION FORMULATION Glycoscience, S.L. (ES) 2025-11-12 EP claimed
US-11976138-B2 Thermally stable cellulose ester compositions and articles made using these compositions EASTMAN CHEMICAL COMPANY (US) 2024-05-07 US claimed
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR WELLA OPERATIONS US, LLC 2019-06-27 US claimed
WO-2018053183-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR NOXELL CORPORATION (US) 2018-03-22 WO claimed
WO-2018053065-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR THE PROCTER & GAMBLE COMPANY (US) 2018-03-22 WO claimed
EP-3295925-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR Noxell Corporation (US) 2018-03-21 EP claimed
WO-2017199145-A1 INSECT REPELLENTS UNIVERSITY OF PRETORIA (ZA) 2017-11-23 WO claimed
CN-106178972-A A kind of preparation method of high temperature resistant PPS gas separation membrane 太原市晋华恒远科技有限公司 2016-12-07 CN claimed
WO-2005013694-A1 INSECT REPULSIVE ALLOMONES FIDELINE (FR) 2005-02-17 WO claimed
US-5833999-A ORGANOLEPTIC THE PROCTOR & GAMBLE COMPANY (US) 1998-11-10 US claimed
EP-0787176-A1 FABRIC SOFTENER COMPOSITIONS WITH REDUCED ENVIRONMENTAL IMPACT THE PROCTER & GAMBLE COMPANY (US) 1997-08-06 EP claimed
WO-1996012785-A1 FABRIC SOFTENER COMPOSITIONS WITH REDUCED ENVIRONMENTAL IMPACT THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO claimed
EP-0479471-B1 Corrosion-inhibited antifreeze/coolant composition containing cyclohexane acid TEXACO DEVELOPMENT CORP (US) 1996-02-28 EP claimed
EP-0479471-A1 Corrosion-inhibited antifreeze/coolant composition containing cyclohexane acid TEXACO DEVELOPMENT CORPORATION (US) 1992-04-08 EP claimed
US-5085791-A Corrosion-inhibited antifreeze/coolant composition containing cyclohexane acid(s) TEXACO CHEMICAL COMPANY (US) 1992-02-04 US claimed
US-20260130863-A1 SLOW-RELEASE FORMULATION GLYCOSCIENCE, S.L. (ES) 2026-05-14 US disclosed
EP-4709710-A1 IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY Arcturus Therapeutics, Inc. (US) 2026-03-18 EP disclosed
US-4140134-A FOR SMOKING MATERIALS FRITZSCHE DODGE & OLCOTT INC. (US) 1979-02-20 US disclosed
US-4109662-A SMOKING FRITZSCHE DODGE & OLCOTT INC. (US) 1978-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130863-A1 SLOW-RELEASE FORMULATION HEXD, GMDS, MAN2A1 FFAR3 1159/4885HDAC3 1918/4885HDAC1 1117/4885
US-20190192408-A1 COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR MAL2, MSH6, OR51E2 FFAR3 1289/4885HDAC3 999/4885HDAC1 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.